Zacks Research Brokers Reduce Earnings Estimates for Bruker Co. (NASDAQ:BRKR)

Bruker Co. (NASDAQ:BRKR - Free Report) - Analysts at Zacks Research dropped their FY2025 earnings estimates for Bruker in a report issued on Wednesday, September 18th. Zacks Research analyst R. Department now expects that the medical research company will post earnings of $3.07 per share for the year, down from their previous forecast of $3.09. The consensus estimate for Bruker's current full-year earnings is $2.61 per share. Zacks Research also issued estimates for Bruker's FY2026 earnings at $3.64 EPS.

Other analysts have also issued reports about the company. Jefferies Financial Group started coverage on Bruker in a report on Monday, June 3rd. They set a "buy" rating and a $85.00 price objective for the company. TD Cowen decreased their price target on Bruker from $74.00 to $72.00 and set a "hold" rating for the company in a report on Wednesday, August 7th. The Goldman Sachs Group dropped their price objective on Bruker from $72.00 to $60.00 and set a "sell" rating on the stock in a research note on Tuesday, July 9th. Wells Fargo & Company assumed coverage on shares of Bruker in a research report on Tuesday, August 27th. They set an "overweight" rating and a $78.00 price target on the stock. Finally, Citigroup reduced their price objective on shares of Bruker from $95.00 to $80.00 and set a "buy" rating for the company in a research report on Wednesday, July 10th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, Bruker currently has a consensus rating of "Moderate Buy" and a consensus target price of $81.40.

Bruker Stock Down 1.1 %

Shares of BRKR traded down $0.72 during trading hours on Friday, reaching $67.54. The stock had a trading volume of 4,172,901 shares, compared to its average volume of 1,032,603. The firm has a 50-day simple moving average of $64.51 and a 200 day simple moving average of $73.04. Bruker has a 12 month low of $53.79 and a 12 month high of $94.86. The company has a current ratio of 1.65, a quick ratio of 0.75 and a debt-to-equity ratio of 1.18. The company has a market capitalization of $9.82 billion, a price-to-earnings ratio of 24.28, a P/E/G ratio of 2.31 and a beta of 1.18.

Bruker (NASDAQ:BRKR - Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The medical research company reported $0.52 EPS for the quarter, hitting analysts' consensus estimates of $0.52. The business had revenue of $800.70 million during the quarter, compared to analysts' expectations of $799.44 million. Bruker had a net margin of 11.29% and a return on equity of 24.92%. The business's quarterly revenue was up 17.4% on a year-over-year basis. During the same period last year, the company posted $0.50 earnings per share.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of BRKR. Principal Securities Inc. purchased a new position in Bruker during the fourth quarter valued at $42,000. Quadrant Capital Group LLC boosted its stake in Bruker by 89.4% in the 4th quarter. Quadrant Capital Group LLC now owns 1,392 shares of the medical research company's stock worth $102,000 after purchasing an additional 657 shares in the last quarter. Panagora Asset Management Inc. purchased a new stake in Bruker during the 4th quarter valued at about $205,000. Norges Bank bought a new stake in Bruker during the 4th quarter valued at about $74,582,000. Finally, Coldstream Capital Management Inc. purchased a new position in Bruker in the fourth quarter worth about $209,000. Hedge funds and other institutional investors own 79.52% of the company's stock.

Bruker Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Monday, September 2nd were given a dividend of $0.05 per share. The ex-dividend date of this dividend was Friday, August 30th. This represents a $0.20 annualized dividend and a yield of 0.30%. Bruker's payout ratio is 7.27%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.